Regeneron antibody cuts risk of COVID-19 death in UK study
Dive Brief: A major study found that Regeneron’s antibody treatment can reduce the risk of death for certain people hospitalized with COVID-19, the first definitive evidence a drug aimed at the coronavirus can lower mortality among the sickest patients. Regeneron’s combination antibody regimen cut the risk of death by 20% in patients who had […]
Trial failure dashes Biogen hopes for next Alzheimer’s drug
Dive Brief: An experimental Alzheimer’s disease treatment developed by Biogen didn’t slow patients’ decline when compared to a placebo in a mid-stage study, leading the Massachusetts-based biotech to halt all work on the drug. Known as gosuranemab, the drug blocks a protein that accumulates in patients’ brain called tau, which is different than the way […]
From ’16 Candles’ to 16 Vaccine project, actor Molly Ringwald stars in Sanofi’s push for meningitis shot
Actor Molly Ringwald is famous for the movie “16 Candles,” but these days she’s more concerned about The 16 Vaccine project with Sanofi. Ringwald, who is mom to a teenager and two preteens, stars in a public service announcement promoting the project. In the ad, she emphasizes how important it was to make sure her 16-year-old daughter […]
Asia—Biogen, Eisai’s Alzheimer’s nod; Stemirna’s $188M mRNA vaccine raise; China-made HER2 ADC
Biogen and partner Eisai’s aducanumab have won a landmark—yet widely criticized—FDA approval for Alzheimer’s disease drug Aduhelm, and the companies are eying a big potential market in Asia. China’s Stemirna Therapeutics raised $188 million for its mRNA COVID-19 vaccine ambitions. Chinese authorities have cleared a homegrown HER2-targeted antibody-drug conjugate by RemeGen for stomach cancer. And more. 1. Biogen’s aducanumab crosses FDA […]